EXCELINDUS Excel Industries Q2 FY26 results (Jul–Sep 2025) and concall
Excel Industries reported a challenging Q2 FY26 with revenue and profit declines driven by subdued agrochemical demand and elevated inventory. However, H1 FY26 showed modest revenue growth. The company is strategically diversifying with new contract manufacturing agreements, biocide capacity expansion, and an upcoming R&D center, aiming to reduce agrochemical dependence and drive future growth, despite expecting Q3 to remain lean.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q2 FY26: revenue up 0.4%, net profit down 44.1% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|
| Revenue | 269 | 196 | 248 | 309 | 270 +0% |
| EBITDA | 49 | 12 | 20 | 42 | 30 −39% |
| Net profit | 34 | 6 | 11 | 34 | 19 −44% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
